Compare Mattel Inc (MAT) vs Viatris Inc (VTRS) Price & Performance

Mattel (MAT) trades at $14.2, down 0.7% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 9.06 and P/S of 0.83, while maintaining solid profitability with a 9.27% net income margin. Recent earnings have been mixed, with a beat in Q1 2026 but misses in prior quarters. The company continues to drive brand engagement through new product launches and collaborations, as highlighted by recent Comic-Con exclusives and partnerships.

The investment outlook is cautiously optimistic, supported by deep-value fundamentals and positive analyst sentiment, but tempered by recent earnings volatility and a negative net cash flow trend. Key opportunities include undervaluation relative to peers and strong brand portfolio; risks involve execution on sales growth and managing debt levels amid economic uncertainties.

Viatris (VTRS) trades at $17.59, up 1.74% today, with a bullish technical signal and consistent earnings beats in recent quarters. The company reported revenue of $14.3B for 2025 but posted a net loss of $3.51B, reflecting margin pressures. Positive pipeline developments include FDA acceptance of a new drug application for fast-acting meloxicam, with a PDUFA date set for December 2026. Cash flow from operations remains strong at $2.32B, supporting debt reduction efforts.

The outlook is mixed: analyst consensus targets $20.00 (13.7% upside), but profitability challenges and high debt levels pose risks. Investment appeal hinges on successful pipeline execution and margin recovery, while competitive and regulatory pressures in the generics market remain key watchpoints for shareholders.